I always tell patients at baseline to expect some nausea or vomiting the day after injecting, but it should never be debilitating, says Dr
The main differences are simply cost and convenience
Kopp K, Glotfelty E, Li Y, et al (2023) Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
GLP-1 agonists, such as liraglutide and semaglutide, are increasingly used in medical weight loss due to their ability to mimic the natural hormone glucagon-like peptide-1, which is, for the most part, responsible for regulating appetite and food intake
When it comes to weight loss, semaglutide has a clear edge over liraglutide